2. Cell Cycle/DNA Damage Epigenetics Apoptosis
  3. HDAC Apoptosis
  4. m-Carboxycinnamic acid bishydroxamide

m-Carboxycinnamic acid bishydroxamide  (Synonyms: CBHA)

Cat. No.: HY-W014004 Purity: 98.0%
COA
SDS
Handling Instructions Technical Support

m-Carboxycinnamic acid bishydroxamide (CBHA) is a histone deacetylase inhibitor. m-Carboxycinnamic acid bishydroxamide modulates histone acetylation sites, alters DNA methylation and epigenetic status, increases global histone acetylation, alleviates transcription repression, and facilitates chromatin remodelling. m-Carboxycinnamic acid bishydroxamide can be used for the research of cloned embryo development and epigenetic regulation.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

m-Carboxycinnamic acid bishydroxamide

m-Carboxycinnamic acid bishydroxamide 화학구조

CAS No. : 174664-65-4

사이즈 가격 재고 수량
5 mg 해외재고보유
10 mg 해외재고보유
50 mg   견적 받기  
100 mg   견적 받기  

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 1 publication(s) in Google Scholar

m-Carboxycinnamic acid bishydroxamide Related Antibodies

Top Publications Citing Use of Products

View All HDAC Isoform Specific Products:

View All Isoforms
HDAC HDAC1 HDAC2 HDAC3 HDAC4 HDAC5 HDAC6 HDAC7 HDAC8 HDAC9 HDAC10 HDAC11 HD1 HD2

  • Biological Activity

  • 순도&문서

  • References

  • 고객리뷰

제품 설명

m-Carboxycinnamic acid bishydroxamide (CBHA) is a histone deacetylase inhibitor. m-Carboxycinnamic acid bishydroxamide modulates histone acetylation sites, alters DNA methylation and epigenetic status, increases global histone acetylation, alleviates transcription repression, and facilitates chromatin remodelling. m-Carboxycinnamic acid bishydroxamide can be used for the research of cloned embryo development and epigenetic regulation[1][2][3].

In Vitro

m-Carboxycinnamic acid bishydroxamide (20 μM; 6 h) treatment of reconstructed androgenetic embryos improves blastocyst formation rate, supports derivation of Ca2+ES cell lines with normal karyotype, pluripotent marker expression, and altered imprinted gene expression and DNA methylation patterns relative to zygote-derived R1 ES cells[1].
m-Carboxycinnamic acid bishydroxamide (5-50 μM; 10 hr) treatment of hand-made cloned buffalo embryos significantly increases blastocyst rate to 63.77% and reduces apoptotic index to 4.36 with 10 μM, while 5 μM increases total cell number to 396.85, and 20 μM increases apoptosis[2].
m-Carboxycinnamic acid bishydroxamide (5-50 μM; 10 hr) treatment of hand-made cloned buffalo embryos increases global H3K9ac levels to IVF blastocyst levels, while 10 μM specifically reduces global H3K27me3 levels (though not to IVF levels)[2].
m-Carboxycinnamic acid bishydroxamide (10 μM; 10 hr) treatment of hand-made cloned buffalo embryos upregulates OCT-4, NANOG, and BCL-XL expression, downregulates BAX expression, and does not alter expression of p53, CASPASE3, DNMT1, DNMT3a, or HDAC1[2].
m-Carboxycinnamic acid bishydroxamide (20 μM; 10 h) treatment of mouse 1-cell cumulus cell SCNT embryos accelerates and enhances histone acetylation at H3K9, H3K18, and H4K5 sites without altering DNA methylation levels[3].
m-Carboxycinnamic acid bishydroxamide (20 μM; 10 h) treatment of mouse cumulus cell SCNT embryos significantly enhances outgrowth formation, proliferation, and Oct4-positive cell abundance in vitro[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

m-Carboxycinnamic acid bishydroxamide Related Antibodies

Real Time qPCR[2]

Cell Line: hand-made cloned buffalo embryos
Concentration: 10 μM
Incubation Time: 10 h
Result: Upregulated OCT-4, NANOG, and BCL-XL expression.
Downregulated BAX expression.
Did not alter expression of p53, CASPASE3, DNMT1, DNMT3a, or HDAC1.

Cell Proliferation Assay[3]

Cell Line: mouse cumulus cell SCNT embryos
Concentration: 20 μM
Incubation Time: 10 h
Result: Significantly enhanced outgrowth formation, proliferation, and Oct4-positive cell abundance.
In Vivo

m-Carboxycinnamic acid bishydroxamide (CBHA) (20 μM; incubation; 6 hours) increases androgenetic embryo blastocyst rate to 18.1%, improves imprinted gene expression patterns in derived CaES cells, and supports chimera formation at rates up to 2.6% with multi-tissue contribution[1].
m-Carboxycinnamic acid bishydroxamide (CBHA) (1-20 μM; in vitro exposure; 10 h post-reconstruction) improves mouse SCNT embryo preimplantation and post-implantation development, increases full-term live offspring rate to 3.6-3.8%, and boosts NT-ES cell derivation efficiency to 59% by enhancing blastocyst quality, reducing apoptosis, and promoting outgrowth proliferation[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: B6D2F1 (8-week-old female; C57BL/6J×DBA/2); 129S2/SvPasCrl (male; 129Sv); SCID Beige (6-week-old male); CD-1[1]
Dosage: 20 μM
Administration: incubation; 6 hours
Result: Increased the blastocyst rate of androgenetic embryos to 18.1%.
Enabled derived CaES cell lines to show a normal 40, XY karyotype, and express pluripotent markers (Oct4, Sox2, Nanog, SSEA-1) at levels similar to zygote-derived R1 ES cells.
Supported derived CaES cell lines to form teratomas containing all three germ layers when injected into SCID Beige mice.
Improved imprinted gene expression patterns in derived CaES cells, with paternal genes Dio3 and U2af1-rs1 and maternal gene H19 matching R1 ES cell levels.
Supported CaES-1 cells to yield a 2.6% chimera rate (11 chimeras from 421 manipulated embryos) with contribution to 9 tissues.
Supported CaES-2 cells to yield a 1.8% chimera rate (8 chimeras from 445 manipulated embryos).
Animal Model: B6D2F1 (female, 8-12 weeks old); ICR (female, 8-12 weeks old, foster)[3]
Dosage: 0.1 μM; 1 μM; 5 μM; 20 μM; 100 μM; 300 μM
Administration: in vitro exposure; 10 h post-reconstruction
Result: Increased blastocyst rates to 71.2% (1 μM) and 69.5% (20 μM) from 2-cell embryos, compared to 32.9% in untreated controls and 54.8% in TSA-treated embryos.
Increased total blastocyst cell count to 63.59 and inner cell mass (ICM) cell count to 18.14 (20 μM), compared to 46.47 and 11.73 in untreated controls.
Reduced apoptotic cell percentage to 7.1% (20 μM), compared to 13.9% in untreated controls.
Increased embryo implantation rate to >60% (1 μM, 20 μM), compared to 28% in untreated controls.
Increased embryo recovery rate at E7.5 to 30% (1 μM, 20 μM), compared to 15% in untreated controls.
Increased gastrulating embryo percentage to 87.5% (1 μM) and 82% (20 μM), compared to 60% in untreated controls.
Yielded live offspring rates of 3.7% (1 μM), 3.8% (5 μM), and 3.6% (20 μM) from transferred 2-cell embryos, compared to 0.8% in untreated controls.
Increased outgrowth formation rate to 86% and NT-ES cell derivation rate to 59% (20 μM), compared to 23% and 10% in untreated controls, respectively.
Increased outgrowth total cell count to 744.7 and Oct4-positive cell count to 74.7 at day 4 (20 μM), compared to 246.4 and 44.1 in untreated controls.
Enhanced outgrowth area expansion over days 2-4 post-plating (20 μM).
분자량

222.20

화학식

C10H10N2O4
CAS No.
Appearance

Solid

Color

White to off-white

SMILES

O=C(C1=CC=CC(/C=C/C(NO)=O)=C1)NO
선적

Room temperature in continental US; may vary elsewhere.
보관
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
용액&용해도
In Vitro: 

DMSO : 25 mg/mL (112.51 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.5005 mL 22.5023 mL 45.0045 mL
5 mM 0.9001 mL 4.5005 mL 9.0009 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • 몰농도 계산기

  • 농도 희석 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
순도&문서

Purity: 98.0%

SDS (393 KB)

COA (244 KB)

Handling Instructions (2659 KB)
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 4.5005 mL 22.5023 mL 45.0045 mL 112.5113 mL
5 mM 0.9001 mL 4.5005 mL 9.0009 mL 22.5023 mL
10 mM 0.4500 mL 2.2502 mL 4.5005 mL 11.2511 mL
15 mM 0.3000 mL 1.5002 mL 3.0003 mL 7.5008 mL
20 mM 0.2250 mL 1.1251 mL 2.2502 mL 5.6256 mL
25 mM 0.1800 mL 0.9001 mL 1.8002 mL 4.5005 mL
30 mM 0.1500 mL 0.7501 mL 1.5002 mL 3.7504 mL
40 mM 0.1125 mL 0.5626 mL 1.1251 mL 2.8128 mL
50 mM 0.0900 mL 0.4500 mL 0.9001 mL 2.2502 mL
60 mM 0.0750 mL 0.3750 mL 0.7501 mL 1.8752 mL
80 mM 0.0563 mL 0.2813 mL 0.5626 mL 1.4064 mL
100 mM 0.0450 mL 0.2250 mL 0.4500 mL 1.1251 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

m-Carboxycinnamic acid bishydroxamide Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

m-Carboxycinnamic acid bishydroxamide174664-65-4CBHAHDACApoptosisHistone deacetylaseshistone acetylation sitesandrogenetic embryonic stem cell linescloned mammalian embryosDNA methylationhistone deacetylasecloned buffalo embryoscloned mouse embryosepigenetic statushuman cancer cellsmouse androgenetic embryo-derived stem cellsInhibitorinhibitorinhibit

최근 본 상품:

온라인 문의

Your information is safe with us. * Required Fields.

상품명

  

Requested Quantity *

고객명 *

 

호칭

메일주소 *

 

전화번호 *

Department

 

회사명 *

City

도

Country or Region *

      

비고

대량구매 문의

Inquiry Information

상품명:
m-Carboxycinnamic acid bishydroxamide
Cat. No.:
HY-W014004
수량:
MCE Japan Authorized Agent:

고객리뷰

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

상품명

  

Lot #

고객명 *

 

메일주소 *

전화번호

 

Department *

회사명 *

 

Country or Region *

비고

SAFETY DATA SHEET (SDS)

English - EN (393 KB) Français - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Español - ES (393 KB) Swedish - SV (393 KB) Italian - IT (393 KB) Korean - KR (393 KB) Portuguese - PT (393 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.